The Latin American Group for Immunodeficiencies (LAGID) was established in 1993 to study the frequency of Primary Immunodeficiencies in the different regions of Latin America and to foster the understanding of the basis of these disorders throughout the medical community, including internists, pediatricians, allergists, and immunologists.
LAGID evolved to a society in 2009, the Latin American Society for Immunodeficiencies (LASID) currently including Argentina, Brazil, Chile, Colombia, Costa Rica, Cuba, Ecuador, Honduras, Mexico, Panama, Paraguay, Peru, Uruguay, and Venezuela. We are looking forward for the inclusion of other countries of Central and South America in a near future.
To increase the knowledge and awareness about Primary Immunodeficiencies among researchers and clinicians involved in the fields of allergy and clinical immunology, as well as physicians from specialties in which these diseases constitute a challenge for their daily practice, like pediatrics, infectious diseases, pulmonology, dermatology, rheumatology, hematology, and transplants.
To serve as a platform to promote initiatives for research in basic and clinical immunology with emphasis in Primary Immunodeficiencies, by providing a common ground for sharing up to date knowledge about the pathogenesis, diagnosis, and treatment of these diseases.
To increase the Latin American Registry for Primary Immunodeficiencies in order to advance the knowledge about these disorders in our region, and promote scientific collaborations in basic and clinical research with scientists all over the world.
To develop initiatives from research groups, as well as established patient organizations, and generate guidelines that foster governments awareness in all countries of Latin America.
Health-related undergraduate and graduate students and researchers in training in the areas of immunology and genetics, general practitioners, medical specialties (immunology and allergy, pediatrics and subspecialties, pulmonology, gastroenterology, hematology, otolaryngology, rheumatology, infectious diseases, hematology, and transplantation medicine), as well as patients organizations and foundations.